Clinical Trials for Adjuvant Therapy

Find clinical trials for adjuvant therapy. Discover research opportunities and treatment options in your area.

15 Active Trials Found

Showing 15 trials on this page

Page 1 of 1

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

NCT ID: NCT07101159

This clinical trial is studying a new treatment approach for women with early-stage breast cancer that is hormone receptor-positive and HER2-negative, which is a common type of breast cancer. The s...

Not yet recruiting

Phase: PHASE2 Type: interventional

Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma

NCT ID: NCT07092449

This clinical trial is studying a new treatment approach for people with locally advanced cancer where the stomach meets the esophagus (called gastroesophageal junction cancer). The study is testin...

Not yet recruiting

Phase: NA Type: interventional

CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients

NCT ID: NCT07019363

This clinical trial is looking at whether adding a type of medication called CDK4/6 inhibitors to standard hormone therapy can help women with a specific kind of early breast cancer called HR+/HER2...

Not yet recruiting

Phase: PHASE3 Type: interventional

Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

NCT ID: NCT07005557

This clinical trial is investigating whether older women (65 years and older) with a specific type of breast cancer can receive treatment without undergoing chemotherapy. The study focuses on women...

Not yet recruiting

Phase: PHASE3 Type: interventional

Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma

NCT ID: NCT06950814

This clinical trial is looking at the potential benefits of a treatment called adjuvant therapy for patients who have had surgery for a rare and aggressive type of liver cancer known as primary hep...

Recruiting

Type: observational Locations: Chengdu, Sichuan, China

Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer

NCT ID: NCT06344156

This clinical trial is studying a new treatment approach for pancreatic cancer that combines a special vaccine designed to target cancer cells (called a neoantigen vaccine) with two other therapies...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chengdu, Sichuan, China, Chengdu, Sichuan, China

Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study

NCT ID: NCT06719206

The RedSedCan Study is a clinical trial aimed at helping people with breast, colorectal, or prostate cancer reduce the amount of time they spend being inactive while undergoing treatment. Researche...

Not yet recruiting

Phase: NA Type: interventional

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

NCT ID: NCT06621459

The MONARCHE29 clinical trial is studying the safety and effectiveness of a medication called Abemaciclib when used alongside hormone therapy for patients with a specific type of breast cancer know...

Recruiting

Type: observational Locations: Brest, , France

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

NCT ID: NCT06581315

This clinical trial is studying a medication called donafenib to see how well it works and how safe it is for patients who have recently had surgery to remove liver cancer (known as hepatocellular ...

Recruiting

Phase: NA Type: interventional Locations: Guangzhou, Guangdong, China

Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer

NCT ID: NCT06361316

This clinical trial is studying a new combination treatment for pancreatic cancer that involves a medication called irinotecan liposome, combined with two other drugs, oxaliplatin and tegafur. The ...

Recruiting

Phase: NA Type: interventional Locations: Nanjing, Jiangsu, China

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

NCT ID: NCT06056336

This clinical trial is exploring a treatment approach for patients with esophageal squamous cell carcinoma, a type of cancer that affects the throat. The study is looking at whether combining a new...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China, Shanghai, Shanghai, China

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

NCT ID: NCT06041776

This clinical trial is investigating the effectiveness and safety of a new drug called Befotertinib compared to another drug, Icotinib, for patients with non-small cell lung cancer (NSCLC) that has...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanjing, , China, Shanghai, , China +1 more

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

NCT ID: NCT05468138

This clinical trial is studying a new treatment approach for patients with a specific type of gastric cancer called MSI-H after they have undergone a major surgery known as D2 radical gastrectomy. ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China

Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer

NCT ID: NCT05292742

This clinical trial is studying two different treatments for women with early-stage breast cancer that tests positive for HER2, particularly those who still have some cancer left after initial trea...

Recruiting

Phase: PHASE2 Type: interventional Locations: Fuzhou, Fujian, China

A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer

NCT ID: NCT05186506

This clinical trial is studying a medication called ensatinib to see how well it works compared to standard chemotherapy treatments for patients with a specific type of lung cancer called ALK-posit...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions